INHSU 2024

8-11 October 2024

Megaron International Convention Centre
Athens, Greece

The 12th International Conference
on Health and Hepatitis
in Substance Users

Register now

 

INHSU 2024 Co-Conveners and Committees

 

Our conference would not be possible without the tireless knowledge and expertise of our local co-conveners, international executive committee, program committee, and other committees. Thank you to everyone involved. 

Vana Sypsa,
Co-Convener

National And Kapodistrian University Of Athens

George Kalamitsis, Co-Convener

Hellenic Liver Patients Association Prometheus

We are excited that Athens will host INHSU 2024. The conference will once again provide a platform for those dedicated to advancing healthcare for people who use drugs worldwide to meet, exchange ideas, collaborate and share challenges and innovative approaches.

Vana Sypsa and and George Kalamitsis

Executive Committee

 

  • Joaquin Cabezas, University Hospital Marques De Valdecilla, Spain
  • Emma Day, INHSU, Australia
  • Jason Grebely, Kirby Institute, UNSW Sydney, and INHSU, Australia
  • Marie Jauffret-Roustide, INSERM, France
  • Natasha Martin, University of California San Diego, US
  • George Papatheodoridis, Medical School of National and Kapodistrian University of Athens & Laiko General Hospital of Athens, Greece
  • Mat Southwell, EuroNPUD, UK

Program Committee

 

  • Philip Bruggman, Arud, Switzerland
  • Monica Ciupagea, UNODC, Romania
  • Melisa Dickie, CATIE, Canada
  • Fotini Leobilla, KETHEA, Greece
  • Niklas Luhmann, WHO, Switzerland
  • Brandon Marshall, Brown University, US
  • Tim Rhodes, University of New South Wales / London School of Tropical Medicine, Australia/UK
  • Jo Neale, Kings College, London, UK
  • Meni Malliori, European Parliament on the EMCDDA Management Board, Greece
  • Tony Martinez, University at Buffalo / Erie County Medical Center, US
  • Brendan Harney, Burnet Institute, Australia
  • Martin Kaberg, Beroendecentrum Stockholm, Sweden
  • Sharon Hutchinson, Glasgow Caledonian University, UK
  • Kirsten Horsburgh, Scottish Drugs Forum, UK
  • Umesh Chawla, Clinton Health Access Initiative (CHAI), India
  • Camila Picchio, Drexel University, Dornsife School of Public Health, US
  • Mina Psichogiou, Associate Professor of Internal Medicine and Infectious Diseases, Laiko General Hospital, Greece
  • Ruth Zimmerman, Robert Koch Institut, Germany
  • Ernst Wisse, Médecins du Monde, France